Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Webcast Transcript

CDC Responds: Coping with Bioterrorism—The Role of the Laboratorian

(November 9, 2001)

(View the webcast on the University of North Carolina School of Public Health site.)

Segment 2 of 9
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
<< previous | contents | next >>

Ms. Lisa Rayam:
As you’ve just heard from Dr. Koplan, the link between the clinical laboratory community and public health laboratories is an essential link in addressing bioterrorism. I’m Lisa Rayam, and welcome to “CDC Responds: Coping with Bioterrorism—The Role of the Laboratorian,” which is the first in a series of programs that will be coming to you live from the CDC in Atlanta. The CDC is dedicated to keeping you, our audience, aware of the latest laboratory guidelines and procedures for addressing threats or actual events related to bioterrorism.

Now, before we continue, here are some important contact numbers you’ll need if you have trouble receiving this program during our broadcast. For technical assistance in the United States, please call 800-728-8232. Our international technical assistance number is 404-639-1289.

And now, let me introduce you to Dr. Fred Tenover, who, along with our first panel of experts from CDC’s National Center for Infectious Diseases, will provide an overview of laboratory issues for responding to bioterrorism incidents, and a preparedness guidance for all laboratories. Dr. Tenover, welcome, and please introduce your panelists.

Dr. Fred Tenover:
Thank you, Lisa. Today we are very pleased to have with us Dr. Tanja Popovic, the chief of the epidemiologic investigations laboratory at CDC; Mr. Richard Kellogg, the interagency liaison and CDC Laboratory Response Network coordinator; and Dr. J. Michael Miller, the chief of the epidemiology and laboratory branch. Our objectives for the program today are: to describe the laboratory tests used to diagnose the current cases of anthrax in the United States; second of all, to describe the structure of the Laboratory Response Network and the rationale for the Level A, B, C, and D laboratories; and then finally, to define the testing performed at the Level A through D laboratories, and the methods that are appropriate for specimen referral.

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
<< previous | contents | next >>

  • Page last updated November 20, 2002
Contact Us:
Ready.gov - Prepare. Plan. Stay Informed.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #